DoP extends timeline to apply for 11 bulk drugs under PLI scheme
The Department of Pharmaceuticals (DoP) has extended the timeline for the industry to apply for the latest round of selection into the production linked incentive (PLI) scheme for bulk drugs. The timeline for submission of applications for the scheme has …